![Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology](https://onlinelibrary.wiley.com/cms/asset/fec1e2e8-1746-4367-ab4d-0b1d79098e29/jdv17623-fig-0001-m.jpg)
Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology
![Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls - Journal of the American Academy of Dermatology Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0102cc09-a191-42d6-a6b9-175193e03049/gr1_lrg.jpg)
Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls - Journal of the American Academy of Dermatology
![JCM | Free Full-Text | Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects | HTML JCM | Free Full-Text | Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects | HTML](https://www.mdpi.com/jcm/jcm-10-04257/article_deploy/html/images/jcm-10-04257-g001.png)
JCM | Free Full-Text | Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects | HTML
![Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-020-00448-x/MediaObjects/13555_2020_448_Fig1_HTML.jpg)
Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink
![Dr. Sergio Vañó on Twitter: "Treatment of male #AndrogeneticAlopecia with oral dutasteride and low dose oral minoxidil. 💊 💊 Early response after 4 months. ➡️ No adverse effects were detected! #tricoHRC #tricologiaGPJ # Dr. Sergio Vañó on Twitter: "Treatment of male #AndrogeneticAlopecia with oral dutasteride and low dose oral minoxidil. 💊 💊 Early response after 4 months. ➡️ No adverse effects were detected! #tricoHRC #tricologiaGPJ #](https://pbs.twimg.com/media/D8I1Ca2WsAAcLNV.jpg:large)
Dr. Sergio Vañó on Twitter: "Treatment of male #AndrogeneticAlopecia with oral dutasteride and low dose oral minoxidil. 💊 💊 Early response after 4 months. ➡️ No adverse effects were detected! #tricoHRC #tricologiaGPJ #
![Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia - Journal of the American Academy of Dermatology Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6325c11a-9de6-41d6-9c31-91a0016c4c2c/gr1.jpg)